Talk:Lists of investigational drugs

This is the talk page for discussing improvements to the Lists of investigational drugs article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find sources: Google (books · news · scholar · free images · WP refs) · FENS · JSTOR · TWL

Lists Low‑importance

	This article is within the scope of WikiProject Lists, an attempt to structure and organize all list pages on Wikipedia. If you wish to help, please visit the project page, where you can join the project and/or contribute to the discussion.ListsWikipedia:WikiProject ListsTemplate:WikiProject ListsList articles
Low	This article has been rated as Low-importance on the project's importance scale.

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Updates needed badly

Large proportion of the mentioned compounds seems have dropped from research. 88.115.35.69 (talk) 02:38, 16 June 2021 (UTC)[reply]

Idiopathic Hypersomnia

Roth Classifications: Roth Type I: Classic Type: Polysymptomatic with EDS (Excessive Daytime Sleepiness), Sleep Drunkenness, Autonomic Instability (Orthostatic Hypotension, Orthostatic Syncope, Raynaud’s Phenomenon, Headaches {Migraines and Tension Headaches), Sleep Drunkenness, Sleep Inertia, Repeat Sleep Latency Testing (RSLT), Sleep Arousal Difficulties, Prolonged Sleep (greater than 12 hours in a single sleep episode) Roth Type II: Excessive Daytime Sleepiness without associated Symptomatology Associated with the “Somnogen” Subtance found in the cerebrospinal fluid in affected patients with hypersensitivity to GABBA alpha receptors responsible for somnolence similar to someone who was given a continuous infusion of Ativan and benzodiazepine-like medications in spite of not taking any such drugs. It’s thought to be genetic, although very rare in patients without the genetic forms of narcolepsy without associated cataplexy Ruth Deerfield, M.D. (talk) 08:20, 31 January 2022 (UTC)[reply]